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Abstract
Background Traditional approaches for nighttime glycemic
control in glycogen storage disease type I (GSDI) include
continuous tube feeding, or ingestion of uncooked corn starch
(CS) at bedtime. A modified corn starch (MCS) has been
shown to prolong euglycemia in some patients. The aim of
this study was to evaluate whether stable nighttime glucose
control can be achieved with other types of slowly digested
carbohydrates in adult GSDI patients.
Methods In this cross-over study, nocturnal glucose control
and fasting times were assessed with three different nocturnal
nutrition regimens in five patients, using continuous glucose
monitoring (CGMS) in an outpatient everyday life setting. For
each patient, continuous glucose profiles were measured after
ingestion of (1) CS, (2) MCS or (3) a pasta meal at bedtime,
during 5 to 6 consecutive nights for each regimen.
Results Stable nocturnal glucose control was achieved for all
patients with a pasta meal, with a mean duration of glycemia
>3.5 mmol/l of 7.6 h (range 5.7-10.8), and >4 mmol/l of 7 h
(5.2-9.2), similar to CS and MCS. Fasting glucose before
breakfast on workdays (after 7.1±0.8 h) was not significantly
different between the three interventions (CS 4.1±0.5 mmol/l,
MCS 4.6±0.7 mmol/l, pasta 4.3±0.9 mmol/l). During
prolonged fasting on weekends, longer duration of
normoglycemia was achieved with CS orMCS than with pasta.
Conclusion Consumption of cooked pasta is a suitable and
more palatable alternative to uncooked corn starch to achieve
nighttime glucose control in adult patients with GSDI.
Introduction
Glycogen storage disease type I (GSDI, van Gierke’s disease
OMIM 232200) is an autosomal recessive disorder with an
incidence of approximately 1:100,000. There are two types
of GSDI, resulting from deficiencies of either glucose-6-
phosphatase (type GSDIa, about 80 % of affected patients)
or the glucose-6-phosphate transporter (type GSDIb) (Chou
et al 2010; Chen et al 2013). The primary metabolic abnor-
mality of all GSDI patients is fasting hypoglycemia, because
glucose-6-phosphate produced either via gluconeogenesis or
glycogenolysis can not be converted to glucose. Other associ-
ated metabolic abnormalities are lactic acidosis, marked
hypertriglyceridemia, hypercholesterolemia, and hyperurice-
mia, depending on the quality of metabolic control. Despite
optimal treatment, many patients with GSDI will develop
complications such as liver adenomas, chronic kidney disease,
urolithiasis, low bone density/osteoporosis, and anemia. Poor
metabolic control is a risk factor for the development of these
complications. Neutropenia and inflammatory bowel disease
(IBD) are characteristic features or complications of GSDIb.
Dietary treatment is the cornerstone of GSDI therapy (Rake
et al 2002; Bhattacharya 2011; Kishnani et al 2014). A regular
Communicated by: Robin Lachmann
* Michel Hochuli
michel.hochuli@usz.ch
1 Division of Endocrinology, Diabetes, and Clinical Nutrition,
University Hospital Zurich, Rämistrasse 100,
CH-8091 Zurich, Switzerland
2 Division of Metabolism and Children’s Research Center, University
Children’s Hospital, Zurich, Switzerland
3 Division of Endocrinology, Diabetology and Clinical Nutrition,
University Hospital of Bern, Inselspital, Bern, Switzerland
4 Endocrinology, Diabetes, and Metabolism, University Hospital
Basel, Basel, Switzerland
5 Radiz – Rare Disease Initiative Zurich, Clinical Research Priority
Program for Rare Diseases, University of Zurich, Zurich, Switzerland
J Inherit Metab Dis (2015) 38:1093–1098
DOI 10.1007/s10545-015-9864-2
carbohydrate intake is necessary to avoid hypoglycemia and
to achieve good metabolic control. Traditional approaches to
maintain normoglycemia during nighttime are continuous
tube feeding (especially in children), or ingestion of slowly
digested carbohydrates at bedtime, usually uncooked corn
starch (CS) (Wolfsdorf and Crigler 1997; Weinstein and
Wolfsdorf 2002; Shah and O'Dell 2013). A modified form of
corn starch (Glycosade®, MCS) with a different content of
amylopectin and resistant starch can prolong euglycemia dur-
ing nighttime in some patients (Bhattacharya et al 2007;
Correia et al 2008). Glucose requirements generally decrease
with age, and adults typically have a longer fasting tol-
erance compared to children, which facilitates overnight
glucose control.
However, studies addressing dietary issues specifically in
adults are scarce. Although standard therapy with uncooked
corn starch (CS), or modified corn starch (Glycosade®, MCS)
generally is well tolerated, some gastrointestinal discomfort
sporadically occurs with bloating, diarrhoea, or in certain
cases abdominal cramps. Given the longer fasting tolerance,
adults may prefer other more palatable or convenient types of
slowly digested carbohydrates before bedtime in certain situ-
ations. However, nutrition regimens other than CS or MCS
have not been formally tested in adults.
Most controlled studies comparing the effects of different
dietary treatments on metabolic control were performed in
standardized inpatient settings, but studies evaluating glucose
homeostasis in everyday life settings are rare. Continuous glu-
cose monitoring systems (CGMS) are now routinely used in
outpatient clinics to evaluate and improve glucose control in
patients with type 1 diabetes mellitus. CGMS is also sporad-
ically being used by some metabolic centers to assess the
quality of glucose control (White and Jones 2011; Kasapkara
et al 2014), but has not been used in controlled studies in
patients with GSDI.
In the present controlled crossover study, nocturnal glyce-
mic control of adult patients with GSDI is evaluated under
three different nighttime nutrition regimens, including the
two standard treatments with CS or MCS, and a pasta meal
(P) as an alternative regimen. The study was performed in an
outpatient everyday life setting, using current CGMS technol-
ogy and capillary glucose measurements.
Materials and methods
Study design
This single centre study consisted of three different nighttime
oral nutrition regimens in a crossover design. For each patient,
continuous glucose profiles (CGMS) were measured in an
outpatient everyday life setting after bedtime ingestion of (1)
uncooked corn starch (CS, Maizena®), (2) modified corn-
starch (MCS, Glycosade®) or (3) a freshly cooked pasta meal
(P). Each type of nutrition regimen was prescribed for 6 con-
secutive days, which corresponds to the maximum time of
uninterrupted sensor (CGMS) data recording. For the CGMS
measurement period with the pasta meal, patients took their
usual diet with corn starch for the first night to ensure stable
sensor function, and pasta was taken for the following 5 con-
secutive nights. Patients returned to their usual nutrition plan
between the interventions (range 3-8 weeks).
Patients
Male or female patients>18 yrs with GSDIa or GSDIb were
eligible for this study. Inclusion criteria were stable nighttime
glucose control under the current dietary treatment with CS or
MCS, and willingness to adhere to the proposed protocol.
Exclusion criteria were unstable nighttime glucose control
with frequent or severe hypoglycemia, the need for gastric
tube feeding, or comorbidities which could adversely affect
the safe participation in the study. Patients were recruited from
the adult metabolic clinics of the University Hospitals in
Zurich, Bern and Basel (Switzerland), on the occasion of a
regular consultation. Eligible patients were screened at the
University Hospital Zurich. Informed consent was obtained
from all patients included in the study. The first patient started
the study in December 2013, the last patient completed the
study in November 2014.
Dietary therapy
For all interventions, patients received detailed oral and writ-
ten dietary instructions by a specialist dietician. Patients were
asked to write a food diary with the exact time of ingested
meals during the CGMS measurement period. For the first
measurement period patients continued the established treat-
ment with the usual type and amount of cornstarch (CS or
MCS, Table 1). For the following two dietary interventions
the prescribed quantity of MCS, CS, or pasta corresponded to
an equivalent amount of carbohydrates (in grams) provided by
the usual dietary treatment (90 g carbohydrates per 100 g CS),
with the option for a dose increase by ~10 g after 2-3 nights. A
conversion factor of 1.1 was used to calculate the amount (in
grams) ofMCS fromCS, according to the specifications of the
manufacturer. The dry weighed amount of CS or MCS was
dissolved in 120 ml of cold water per 60 g of cornstarch, and
consumed immediately after mixing in a shaker. No carbohy-
drates other than cornstarch were allowed at bedtime. For the
pasta meal, patients received prepacked weighed portions of
dried, commercially available italian pasta (BPenne rigate^,
Barilla®, containing 72 g of carbohydrates per 100 g dry pas-
ta). Pasta was freshly cooked in boiling water by the patients
before bedtime, with a standardized cooking time of 11 min to
obtain a consistency which can be described as ‘firm to the
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bite’ (‘al dente’). Patients were allowed to use a small amount
of commercial tomato sauce (Sauce Napoletana, Barilla®) or
oil for the meal.
On workdays, the first meal in the morning was taken at the
usual time outside the study, unless low blood glucose would
necessitate earlier intake of carbohydrates. On weekends,
breakfast was delayed to assess the glucose curve with
prolonged fasting under the given dietary regimen. Partici-
pants were advised that the latest time to eat breakfast is when
hypoglycemia occurs. There is no uniformly accepted defini-
tion of hypoglycemia. In patients without diabetes probably
the best definition is neuroglycopenia (Wiesli et al 2002). In
this study hypoglycemia was defined as a glucose concentra-
tion of ≤2.5 mmol/l without symptoms of hypoglycemia, or
symptoms of hypoglycemia and a capillary blood glucose
<3.1 mmol/l. Average fasting times on weekends were
assessed for glucose cut-off values of >3.5 mmol/l and
>4 mmol/l, in accordance with recommended preprandial
blood glucose targets in European (>3.5-4.0 mmol/l) and
American guidelines (>3.8 mmol/l, 70 mg/dl) (Rake et al
2002; Kishnani et al 2014).
Continous glucose measurements
An unblinded continuous glucose monitoring system
(CGMS) was used during the dietary interventions (Enlite®
glucose sensors combined with the Minilink® Real Time
Transmitter, MedTronic®). A Minimed Paradigm Veo® insu-
lin pump (void of insulin) was used to store and display sensor
results. Patients were instructed to use the CGMS system by
specialist diabetes nurses or the investigator. The sensor was
placed on the abdomen, and used according to the
manufacturers’ specifications. Patients regularly performed
capillary glucose measurements (device: Contour Next Link
USB, Bayer®) to calibrate the glucose sensor (at least 3 times/
day) and to check for accurate sensor function. All patients
made a capillary glucose measurement before the first meal in
the morning in addition to the sensor readings. An alarm was
set to warn patients in case of nocturnal hypoglycemia (thresh-
old <2.5 mmol/l). Confirmation of hypoglycemia by a capil-
lary glucose measurement was mandatory in case of an alarm
prior to carbohydrate intake. CGMS data were downloaded
with the Carelink Professional® Software (MedTronic®) for
statistical analysis, and discussed with the patients.
Data analysis and statistics
Data are presented as arithmetic means with standard devia-
tion or ranges. Nine nights of CGMS data with unstable tech-
nical sensor function and a clear discrepancy of the sensor
reading to the capillary glucose measurements were omitted
from the analysis. Statistical analysis was performed using the
statistical package SPSS 22 (IBMSPSS Statistics). A two-sided
value of P<0.05 was considered significant. Post-hoc sequen-
tial Bonferroni correction was applied to account for multiple
comparisons. The effect of the interventions on fasting glucose
and the fasting time was examined using multiple linear regres-
sion (Senn 2002), always controlling for between-patient dif-
ferences. For comparison of capillary and sensor fasting glu-
cose measurements, a paired samples t-test was applied. The
rate of decline of the glucose concentration during nighttime
was assessed by linear regression (curve fit) of the glucose
sensor curves, using Graph Pad Prism® Version 6.
Table 1 Patient characteristics
Patient, sex Age
[y]













1, M 21 1b G6PT1
c.250 T>A,homozygous
70 23.4 7.1 MCS
1.7 g/kg
3 – 4.5 h
2, F 35 1b G6PT1
c.1211delCT/c.1348G>A
78 33.8 1.5 CS
1.7 g/kg
2.5 – 3.5 h
3, M 30 1a G6PC
c.407G>A/c.675A>G
0.5 87 28.7 5.4 CS
1.4 g/kg
3 – 4 h
4, M 35 1a n.a. 0.4 59 19 3.4 CS
1.0 g/kg
3 – 4 h
5, F 19 1a n.a. n.a. 62 24.2 6.0 CS
1.3 g/kg
3.5 – 4 h
1 Glucose-6-phosphatase activity in liver (normal 3.7-9.7 U/g)
2 Average of measurements during regular medical visits during the last 2 years prior to inclusion to the study (normal<1.7 mmol/l)
3 CS uncooked corn starch, MCSmodified corn starch (Glycosade®). Corn starch is taken as a single dose before bedtime in the given amount. Patient 4
is undertreated, because he does not tolerate higher amounts of CS
4 Approximate average minimal fasting times during the day (without CS, MCS or P), according to CGMS curves and capillary glucose measurements.
All patients participating in the study need regular carbohydrate intake every 3-4 h during the day to maintain normoglycemia. Patients 2 and 3 had one
episode of severe hypoglycemia (requiring assistance) during the day in recent years.
n.a. not available
J Inherit Metab Dis (2015) 38:1093–1098 1095
Results
Five patients with GSDI fulfilled the inclusion criteria (three
GSDIa, two GSDIb). All patients had stable overnight glucose
control under their established dietary treatment with a single
intake of cornstarch before bedtime. Uncooked corn starch (CS)
was the usual treatment for four patients included in this study,
one patient used modified cornstarch (MCS, Glycosade®). The
characteristics of the patients are summarized in Table 1. All
patients had confirmed diagnosis of GSDI by molecular genet-
ics or enzyme testing in a liver biopsy sample.
During the CGMS measurement periods, the actual aver-
age amounts of cornstarch (as a single dose) ingested before
bedtime were 100±28 g of CS, or 109±29 g of MCS respec-
tively. The actual average amount of pasta (dry weight) con-
sumed before bedtime was 136±33 g. These quantities corre-
spond to 90 g of carbohydrates for CS andMCS, and a slightly
higher amount of 98 g for the pasta meal (P). Glucose sensor
function was reliable for an average number of 4.7 nights per
intervention and patient (range 3-6), according to capillary
glucose measurements.
All patients achieved stable glucose control during each
night with a pasta meal at bedtime, with a mean duration of
glycemia >3.5mmol/l of 7.6 h (range 5.7-10.8), and >4mmol/
l of 7 h (5.2-9.2), similar to the results obtained for CS and
MCS (Fig. 1). Nocturnal hypoglycemia was not observedwith
any of the three dietary regimens. The first meal in the morn-
ing was taken on average 8.0±1.6 h after bedtime intake of
carbohydrates for all nutrition regimens. The shape and char-
acteristics of the nocturnal sensor glucose curves were similar
for all three nutrition regimens, although the linear rate of
decline of glucose concentration after reaching the plateau
was somewhat slower for MCS (MCS 0.21±0.01 mmol/l*h,
as compared to CS and P 0.29±0.01 mmol/l*h, p<0.001).
Glucose concentrations at bedtime were comparable between
the regimens (CS 5.3±1.3 mmol/l, MCS 5.1±0.8 mmol/l,
pasta 4.7±0.9 mmol/l, differences ns), and the time to peak
glucose after the bedtime meal was between 1 h and 1.5 h for
all interventions (peak at 5.9 mmol/l after 1 h for CS,
6.1 mmol/l after 1.5 h for MCS, 6.2 mmol/l after 1.1 h for pasta,
ns). On workdays, when the first meal in the morning was
taken at the usual time outside the study, capillary fasting
glucose concentrations before breakfast were not significantly
different between the three regimens, although there was a
trend for slightly higher values with modified cornstarch (CS
4.1±0.5 mmol/l, MCS 4.6±0.7 mmol/l, pasta 4.3±0.9 mmol/
l, ns) (Fig. 2). Sensor readings of fasting glucose were similar
to capillary values, with no statistically significant differences.
Average fasting times from bedtime to breakfast on workdays
were 7.1 h (5.5-8.5) for CS, 7.1 h (5.6-7.7) for MCS, and 6.9 h
(5.7-8.2) for P (ns). During the weekend, patients were asked
to delay breakfast to assess the kinetics of glucose concentra-
tion with prolonged fasting. While stable nocturnal glucose
control was achieved for all patients with a pasta meal when
the breakfast was taken at the usual time, longer duration of
normoglycemia could be achieved for some patients with CS
and MCS than with pasta during the prolonged fasting on
weekends (Fig. 3). The average fasting times with stable glu-
cose >4 mmol/l during weekends were 8.3 h (5.3-10) for CS,
8.9 h (6.8-10.5) for MCS, and 7.2 h (6.2-8.2) for P. The aver-
age times with stable glucose >3.5 mmol/l were 9.2 h (6.9-11)
for CS, 9.3 h (7.4-11.2) for MCS, and 8.7 h (7.8-10.3) for P
(Fig. 3). Although the fasting times were not significantly
longer with MCS for the whole group of patients, two patients
(Nr. 4 and 5, Table 1) achieved relevantly longer fasting times
(1.5-2 h) with glucose>4 mmol/l using MCS as compared to
CS (p<0.01 MCS vs CS).
Discussion
This study demonstrates that in adult patients with GSDI al-
ternative sources of carbohydrates such as a pasta meal before
bedtime can maintain normoglycemia during the night to the
same extent as uncooked corn starch. To the best of our
knowledge, this is the first controlled interventional study in
patients with GSDI using current CGMS technology to mon-
itor glucose control in an outpatient setting resembling every-
day life. The primary goal of dietary therapy in GSDI is stable
normoglycemia. For adults, uncooked corn starch is the stan-
dard dietary regimen to achieve nighttime glucose control, and























Fig. 1 Nocturnal glucose curves for three different nutrition regimens at
bedtime. Brown line: uncooked corn starch (CS). Blue line: modified
corn starch (MCS). Red line: pasta meal (P). The solid lines represent
the mean glucose concentration, with the standard deviation indicated by
the dotted lines. Curves were recorded by subcutaneous continous
glucose measurement (CGMS). All patients achieved stable nighttime
glucose control with a pasta meal at bedtime, similar to the results
obtained for CS and MCS. Number of measurements per intervention:
CS n=24, MCS n=23, pasta n=24. The vertical line indicates the average
time until ingestion of the first meal in the morning. The bedtime meal is
ingested at time-point zero
1096 J Inherit Metab Dis (2015) 38:1093–1098
single ingestion of corn starch at bedtime. Most patients are
habituated to the use of cornstarch since childhood and are not
adversely affected by this treatment. Although we do not
advocate a permanent replacement of the established treat-
ment with corn starch by cooked pasta, cooked pasta can be
a more palatable alternative to corn starch to achieve nighttime
glucose control in certain situations, and to allow for variety in
choice. For an equivalent amount of carbohydrates, more cal-
ories are delivered with a pasta meal than with corn starch
dissolved in water (e.g. +70-100 kcal for 126 g dry pasta
compared to 100 g cornstarch, +70 kcal for a small serving
of tomato sauce). Care has to be taken to avoid excessive
calorie intake and overtreatment, considering that overweight
is a frequent problem for patients with GSDI. Pasta is a slowly
digested form of carbohydrate, since the compact structure
created during the extrusion process in production of dry pasta
leads to a dense protein network that reduces the availability
of starch granules and their rate of breakdown by amylases
(Fardet et al 1999; Aravind et al 2013). In this study, pasta was
cooked just before the meal in order to guarantee good stan-
dardization. However, cooked pasta stored in the refrigerator
(e.g. as pasta salad) is assumed to be at least equivalent to
freshly cooked pasta, and may even have a more favourable
glycemic profile with slower glucose release, due to retrogra-
dation of starch (i.e. formation of microcrystalline structures
of resistant starch from gelatinized starch (Riva et al 2000).
We postulate that dry industrial pasta freshly cooked ‘al dente’
can substitute CS. Cooking should be firm to the bite (‘al
dente’) to achieve adequate fasting times, and overcooking
should be avoided. Different glycemic responses and fasting
times may be obtained with other types of pasta. BPenne^
were chosen for this study because of ease of standardization
of the cooking procedure. Spaghetti may also be suitable due
to a higher product density with compact structure, depending
on the fabrication process (Wolever et al 1986; Bjorck et al
1994). Indeed, before this study was initiated, one of our
patients who does not tolerate CS or MCS, but normally
relies on overnight gastric tube feeding, consumed spa-
ghetti meals instead of tube feeding at several occasions
when using continuous glucose monitoring, and
achieved good and stable glucose control (this patient
was not included in the study).
The present study did not demonstrate a significant benefit
of MCS compared to CS with respect to fasting time in the
overall study population, although two of five patients
achieved relevantly longer glucose control with MCS. How-
ever, the present study was designed to demonstrate stable
nocturnal glucose control with alternative carbohydrates such
as a pasta meal, and may not be powered to delimit differences
between the two preparations of cornstarch. In an inpatient
controlled trial, MCS has been shown to prolong fasting in
some patients by 1-2 h compared to CS, however most of the
benefit was noted after glucose values fell below 3.9 mmol/l
(Correia et al 2008). In general, children and young adults
have shorter fasting tolerance and possibly may profit to a
greater degree from therapy with MCS, although this has not
been proven in controlled studies.
The present study confirms that CGMS is a reliable tool to
monitor glycemic control in patients with GSDI in an outpa-



















Fig. 2 Fasting glucose from capillary and sensor measurements. Bars
represent arithmetic means of glucose concentration with standard
deviation, measured on workdays when the first meal was taken at the
usual time, on average 7.1 h (range 5.5-8.5) after bedtime. Fasting glucose
concentrations were not significantly different between the three
regimens. The dotted horizontal line indicates a glucose limit
>3.5 mmol/l. (CS) uncooked corn starch, (MCS) modified corn starch,
(P) pasta meal












Fig. 3 Average fasting times when breakfast is delayed at weekends. (a)
Stable glucose >4 mmol/l. (b) Stable glucose>3.5 mmol/l. The vertical
line indicates the arithmetic mean, the points represent average fasting
times of individual patients, identified by different symbol shapes (●
patient 1, ▲ patient 2, ✖ patient 3, ◆ patient 4, ◼ patient 5). (CS)
uncooked corn starch, (MCS) modified corn starch, (P) pasta meal
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unblinded real time CGMS was used to protect patients from
potential nocturnal hypoglycemia. Because of stable glucose
control, carbohydrate intake was not necessary during night-
time. We therefore assume that usage of this unblinded system
did not affect the results of our study. (2) This study focuses on
nocturnal glucose control, and the outpatient study design
precluded measurements of lactate and triglyceride concentra-
tions under the different nutrition regimens. However, the
concentrations of these metabolite also depend on daytime
glucose control and the amount of ingested sucrose/fructose
or fat during the day, which have not been controlled in this
study. Several dietetic studies with GSDI were performedwith
inpatients in a strictly controlled environment. Although this
approach is helpful to reveal small differences between vari-
ous nutrition regimens, it does not reproduce normal daily life
and usual patient activity levels in an outpatient setting.
In conclusion, the present study clearly demonstrates that
adult patients with GSDI achieve stable nocturnal glucose
control with alternative slowly digested carbohydrates such
as a pasta meal, and modified cornstarch may prolong fasting
times compared to uncooked corn starch in some patients. In
practice, large intra- and interindividual differences in glucose
response to diet are common, and the optimal mode to deliver
carbohydrates remains to be tailored to the individual patient.
More prospective studies are needed to assess effects of dif-
ferent dietary treatment options on long-term outcome and
quality of life in GSDI.
Acknowledgments This work was supported by ‘radiz – Rare Disease
Initiative Zurich, Clinical Research Priority Program University of Zu-
rich’. The authors thank patients for participation in this study. We thank
Claudia Morach for dietetic advice and instruction of patients, and Ilona
Kehret for the help in glucose sensor instruction.
Conflict of interest Michel Hochuli, Emanuel Christ, Fabian
Meienberg, Roger Lehmann, Jan Krützfeldt and Matthias Baumgartner
declare that they have no conflict of interest.
References
Aravind N, Sissons M, Fellows CM, Blazek J, Gilbert EP (2013)
Optimisation of resistant starch II and III levels in durum wheat
pasta to reduce in vitro digestibility while maintaining processing
and sensory characteristics. Food Chem 136:1100–1109
Bhattacharya K (2011) Dietary dilemmas in the management of glycogen
storage disease type I. J Inherit Metab Dis 34:621–629
Bhattacharya K, Orton RC, Qi X et al (2007) A novel starch for the
treatment of glycogen storage diseases. J Inherit Metab Dis 30:
350–357
Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food prop-
erties affecting the digestion and absorption of carbohydrates. Am J
Clin Nutr 59:699s–705s
Chen Y-T, Kishnani PS, Koeberl D (2013) Glycogen storage diseases. In:
Beaudet AL, Vogelstein B, Kinzler KW et al (eds) The online met-
abolic and molecular bases of inherited disease New York. The
McGraw-Hill Companies, Inc., NY
Chou JY, Jun HS, Mansfield BC (2010) Glycogen storage disease type I
and G6Pase-beta deficiency: etiology and therapy. Nat Rev
Endocrinol 6:676–688
Correia CE, Bhattacharya K, Lee PJ et al (2008) Use of modified corn-
starch therapy to extend fasting in glycogen storage disease types Ia
and Ib. Am J Clin Nutr 88:1272–1276
Fardet A, Abecassis J, Hoebler C et al (1999) Influence of technological
modifications of the protein network from pasta on in vitro starch
degradation. J Cereal Sci 30:133–145
Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014)
Continuous glucose monitoring in children with glycogen storage
disease type I. Eur J Clin Nutr 68:101–105
Kishnani PS, Austin SL, Abdenur JE et al (2014) Diagnosis and manage-
ment of glycogen storage disease type I: a practice guideline of the
American College of Medical Genetics and Genomics. Genet Med :
Off J Am Coll Med Genet 16, e1
Rake JP, Visser G, Labrune P et al (2002) Guidelines for management of
glycogen storage disease type I - European Study on Glycogen
Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):
S112–S119
Riva M, Fessas D, Schiraldi A (2000) Starch retrogradation in cooked
pasta and rice. Cereal Chem 77:433–438
Senn S (2002) Crossover trials in clinical research. Wiley Publishing,
Chichester
Shah KK, O'Dell SD (2013) Effect of dietary interventions in the main-
tenance of normoglycaemia in glycogen storage disease type 1a: a
systematic review and meta-analysis. J Hum Nutr Diet : Off J Br
Diet Assoc 26:329–339
Weinstein DA, Wolfsdorf JI (2002) Effect of continuous glucose therapy
with uncooked cornstarch on the long-term clinical course of type 1a
glycogen storage disease. Eur J Pediatr 161(Suppl 1):S35–S39
White FJ, Jones SA (2011) The use of continuous glucose monitoring in
the practical management of glycogen storage disorders. J Inherit
Metab Dis 34:631–642
Wiesli P, Brandle M, Schwegler B, Lehmann R, Spinas GA, Schmid C
(2002) A plasma glucose concentration below 2.5 mmol L-1 is not
an appropriate criterion to end the 72-h fast. J Intern Med
252:504–509
Wolever TM, Jenkins DJ, Kalmusky J et al (1986) Glycemic response to
pasta: effect of surface area, degree of cooking, and protein enrich-
ment. Diabetes Care 9:401–404
Wolfsdorf JI, Crigler JF Jr (1997) Cornstarch regimens for nocturnal
treatment of young adults with type I glycogen storage disease.
Am J Clin Nutr 65:1507–1511
1098 J Inherit Metab Dis (2015) 38:1093–1098
